Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-08-02
DOI
10.1093/jac/dkz374
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Reappraisal of Linezolid Dosing in Renal Impairment to Improve Safety
- (2019) Ryan L. Crass et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors for linezolid-induced thrombocytopenia in patients without haemato-oncologic diseases
- (2018) Go Wun Choi et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study
- (2018) Hyung-Sook Kim et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Predictors of Inadequate Linezolid Concentrations after Standard Dosing in Critically Ill Patients
- (2016) Max Taubert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic drug monitoring in the era of precision medicine: opportunities!
- (2016) Serge Cremers et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Risk factors associated with high linezolid trough plasma concentrations
- (2016) L. Morata et al. EXPERT OPINION ON PHARMACOTHERAPY
- Therapeutic drug monitoring in the past 40 years of the Journal of Antimicrobial Chemotherapy
- (2016) David Reeves et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis
- (2016) Akosua Adom Agyeman et al. Annals of Clinical Microbiology and Antimicrobials
- Linezolid underexposure in a patient co-treated with venlafaxine
- (2015) Piergiorgio Cojutti et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid
- (2014) Lauren M. Boak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight
- (2014) Takashi Niwa et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients
- (2014) H.-Y. Dong et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation
- (2014) P. Cojutti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical experience with linezolid for the treatment of orthopaedic implant infections
- (2014) L. Morata et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk Factors for a Low Linezolid Trough Plasma Concentration in Acute Infections
- (2013) Laura Morata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria
- (2013) Javier Cobo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia
- (2013) Y. Nukui et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Successful Long-Term Treatment of Cerebral Nocardiosis with Unexpectedly Low Doses of Linezolid in an Immunocompromised Patient Receiving Complex Polytherapy
- (2012) Federico Pea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk Factors for Thrombocytopenia in Adult Chinese Patients Receiving Linezolid Therapy
- (2012) Chao Chen et al. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
- (2012) F. Pea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic drug monitoring of antimicrobials
- (2011) Jason A. Roberts et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
- (2010) F. Pea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction
- (2010) Kazuaki Matsumoto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy
- (2010) Yoshiko Takahashi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Linezolid: a review of safety and tolerability
- (2009) Donald C. Vinh et al. JOURNAL OF INFECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started